This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MTAC MedTech Acquisition (MTAC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About MedTech Acquisition Stock (NASDAQ:MTAC) 30 days 90 days 365 days Advanced Chart Remove Ads Get MedTech Acquisition alerts:Sign Up Key Stats Today's Range$8.96▼$12.8350-Day Range$9.34▼$11.3452-Week Range$8.43▼$12.83Volume183,276 shsAverage Volume9,656 shsMarket Capitalization$83.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States. The company was incorporated in 2020 and is based in Greenwich, Connecticut. MedTech Acquisition Corporation operates as a subsidiary of Medtech Acquisition Sponsor LLC.Read More… Remove Ads Receive MTAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedTech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address MTAC Stock News HeadlinesBoston Scientific announces acquisition of the remaining stake in Bolt MedicalJanuary 8, 2025 | seekingalpha.comBoston Scientific to Buy Medical-Technology Company CortexNovember 4, 2024 | marketwatch.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 4, 2025 | Porter & Company (Ad)SMTI Sanara MedTech Inc.July 20, 2024 | seekingalpha.comSurmodics going private in $627 million acquisition by GTCRMay 29, 2024 | bizjournals.comMedTech Acquisition Corporation Registered Shs hosts conference call for investorsMay 11, 2024 | markets.businessinsider.comJohnson & Johnson’s MedTech performance augurs well for industry: analystsJanuary 23, 2024 | msn.comJohnson & Johnson’s earnings beat estimates with boost from medtech salesJanuary 23, 2024 | msn.comSee More Headlines MTAC Stock Analysis - Frequently Asked Questions What other stocks do shareholders of MedTech Acquisition own? Based on aggregate information from My MarketBeat watchlists, some other companies that MedTech Acquisition investors own include Ginkgo Bioworks (DNA), BYD (BYDDY), Spire Global (SPIR), Altimeter Growth (AGC), ARK Innovation ETF (ARKK), Berkshire Hathaway (BRK.B) and Coinbase Global (COIN). Company Calendar Today4/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:MTAC CIK1826667 WebN/A Phone908-391-1288FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$5.54 million Net MarginsN/A Pretax MarginN/A Return on Equity-17.92% Return on Assets-1.48% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.89 per share Price / Cash Flow12.80 Book Value($2.04) per share Price / Book-5.56Miscellaneous Outstanding Shares7,390,000Free Float1,952,000Market Cap$83.80 million OptionableNot Optionable Beta-0.04 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:MTAC) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedTech Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share MedTech Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
